GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Encision Inc (OTCPK:ECIA) » Definitions » FCF Yield %

ECIA (Encision) FCF Yield % : 0.81 (As of Mar. 29, 2025)


View and export this data going back to 1996. Start your Free Trial

What is Encision FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Encision's Trailing 12-Month Free Cash Flow is $0.05 Mil, and Market Cap is $5.68 Mil. Therefore, Encision's FCF Yield % for today is 0.81%.

The historical rank and industry rank for Encision's FCF Yield % or its related term are showing as below:

ECIA' s FCF Yield % Range Over the Past 10 Years
Min: -29.47   Med: -3.59   Max: 12.28
Current: 0.81


During the past 13 years, the highest FCF Yield % of Encision was 12.28%. The lowest was -29.47%. And the median was -3.59%.

ECIA's FCF Yield % is ranked better than
62.8% of 871 companies
in the Medical Devices & Instruments industry
Industry Median: -2.07 vs ECIA: 0.81

Encision's FCF Margin % for the quarter that ended in Dec. 2024 was -4.48%.


Encision FCF Yield % Historical Data

The historical data trend for Encision's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Encision FCF Yield % Chart

Encision Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.70 2.22 -4.09 -21.17 1.20

Encision Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.43 -0.72 7.94 3.18 -5.31

Competitive Comparison of Encision's FCF Yield %

For the Medical Instruments & Supplies subindustry, Encision's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Encision's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Encision's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Encision's FCF Yield % falls into.


;
;

Encision FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Encision's FCF Yield % for the fiscal year that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=0.107 / 8.89425
=1.20%

Encision's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.071 * 4 / 5.346
=-5.31%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Encision FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Encision FCF Yield % Related Terms

Thank you for viewing the detailed overview of Encision's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Encision Business Description

Traded in Other Exchanges
N/A
Address
6797 Winchester Circle, Boulder, CO, USA, 80301
Encision Inc is a medical device company. The company develops and markets technology that provides unprecedented outcomes and patient safety in minimally invasive surgery. The company has established and developed AEM (Active Electrode Monitoring) technology and surgical instruments which provide surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures while preventing stray electrosurgical energy that can cause complications and even death. The segments of the company are Product and Service. Product designs develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities. Maximum revenue is generated from the product segment.
Executives
Robert H Fries director 800 FILLMORE ST, DENVER CO 80206
Gregory J. Trudel director, officer: CEO 5241 RIMROCK LANE, FORT COLLINS CO 80526
Peter D Geary officer: VP of Operations 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Jason E Johnson officer: VP Sales 17752 WEDGEWOOD LANE, PRIOR LAKE MN 55372
Patrick R Dixon director 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Brian J Jackman director 6797 WINCHESTER CIRCLE, SUITE 100, BOULDER CO 80301
Von Der Lippe Paul director 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Denise Baker director 6797 WINCHESTER CIRCLE, BOULDER X1 80301
Vern D Kornelsen director, 10 percent owner 4605 S. DENICE DR, ENGLEWOOD CO 80111
Partners Lllp Cmed 10 percent owner
Patrick W Pace director 3701 SOARING EAGLE, AUSTIN TX 78746
Michael Biggs officer: VP Engineering 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Brad Greathouse officer: VP RA/QA 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Valerie Ray officer: VP of Operations 6797 WINCHESTER CIRCLE, BOULDER CO 80301
David W Newton director, officer: VP Technology 8099 NORTH 63RD STREET, LONGMONT CO 80503

Encision Headlines

From GuruFocus

Encision Reports First Quarter Fiscal Year 2020 Results

By PRNewswire PRNewswire 08-12-2019

Encision Receives PPP Financing

By PRNewswire PRNewswire 02-10-2021

Encision Completes Private Placement of Common Stock

By PRNewswire PRNewswire 12-20-2018

Encision Reports First Quarter Fiscal Year 2022 Results

By PRNewswire PRNewswire 08-09-2021

Encision Reports First Quarter Fiscal Year 2021 Results

By PRNewswire PRNewswire 08-07-2020

Encision Signs Supply Agreement with Auris Health, Inc.

By PRNewswire PRNewswire 08-24-2021

Encision Reports Second Quarter Fiscal Year 2020 Results

By PRNewswire PRNewswire 11-06-2019

Encision Signs Supplier Agreement with Human Xtensions

By ACCESSWIRE ACCESSWIRE 02-28-2023

Encision Reports Second Quarter Fiscal Year 2022 Results

By PRNewswire PRNewswire 11-10-2021